Multiple myeloma
CAR-T, bispecifics, and CD38 franchises racing across earlier lines of therapy.
Lenses
EarlierApproval →
JNJApprovedcash ok
2026-09-12 (30d)Company-guided
Darzalex CD38 franchise · NCT02076009 · Myeloma franchise update
LEGNApprovedcash ok
2026-10-18 (66d)Company-guided
Carvykti BCMA CAR-T · NCT04181827 · Earlier-line myeloma update
BMYApprovedcash ok
2026-11-05 (84d)Company-guided
Abecma BCMA CAR-T · NCT03361748 · CAR-T myeloma competitive update
REGNPh3cash ok
2026-12-14 (123d)Company-guided
BCMAxCD3 bispecific myeloma · NCT05137054 · Myeloma bispecific Phase 3